Eric Heil

Eric Heil is a seasoned professional in the life sciences and healthcare sectors, currently serving as Managing Partner at Medical Excellence Capital, LLC, where leadership focuses on early-stage venture funding leveraging a broad network of experts. Experience includes roles as Board Observer for GC Therapeutics and Board Member for Nobias Therapeutics, both part of the MEC portfolio, as well as Chair and Board Member at ProJenX, Inc., a company co-founded with Project ALS and Columbia University. Previously, Eric held senior positions including SVP at Health Quality Partners and Chief Commercial Officer at naviHealth, and co-founded Upward Health and RightCare Solutions, enhancing care delivery for complex patient populations. Educational credentials include an MBA from The Wharton School and a BSE in Systems Engineering from the University of Pennsylvania.